Evidence map›Paper›PMID 42744831›Full record

ArticleNature communications2026

Intracellular artificial DNA receptor-loaded gelated cells for aflatoxin theranostics.

Lidandi Zhen, Xiaojie Meng, Jing Wen, Xi Zhang, Yue Huang, Wenda Wu, Chao Li, Baocai Xu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lidandi ZhenSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China.
Xiaojie MengSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China.
Jing WenSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China.
Xi ZhangSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China.
Yue HuangDepartment of Food Science and Engineering, College of Light Industry and Food Engineering, Nanjing Forestry University, Nanjing, PR China.
Wenda WuSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China. wuwenda@hfut.edu.cn.
Chao LiSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China. lchao@hfut.edu.cn.ORCID 0000-0002-2552-413X
Baocai XuSchool of Food and Biological Engineering, Engineering Research Center of Bio-Process, Ministry of Education, Hefei University of Technology, Hefei, PR China.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82472103Natural Science Foundation of Anhui Province (Anhui Provincial Natural Science Foundation) 2308085MB55
6 · The paper itself

Abstract

Aflatoxin B1 (AFB1) is one of the most common mycotoxins, which causes severe hepatic damage and even liver cancer. However, the development of specific tools for AFB1 diagnosis and detoxification remains elusive. Herein, we develop a DNA receptor-loaded gelated cell (DR-GC)-based adsorbent for specifically capturing and detecting AFB1, both in vitro and in vivo. In this system, fragile living cells are transformed into robust GCs using an intracellular hydrogel technique, and then loaded with aptamer-based artificial DNA receptors inside cells via a polymer-assisted strategy. These intracellular DNA receptors are excluded from a hostile environment, which exhibits high stability and retains their functionality even in complex biological media. Consequently, DR-GCs can be used to sensitively detect AFB1 and efficiently eliminate AFB1, both in vitro and in vivo. We also demonstrate the excellent therapeutic efficacy of DR-GCs using AFB1-treated male mouse models. Overall, this study is anticipated to offer useful solutions to the development of safe and effective tools for the diagnosis, elimination and treatment of mycotoxins.

Indexed as

Aflatoxin B1DNAAnimalsAptamers, NucleotideHep G2 CellsHumansHydrogelsMaleMiceAflatoxin B1Aptamers, NucleotideDNAHydrogels

Identifiers

PMID42744831
PMCPMC13578302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.